Ophthalmology

The procurement process detailed in this document involves NHS Mid and South Essex Integrated Care Board (MSE ICB) awarding a contract for ophthalmology services, classified under the health services category, to providers within the region UKH3. The awarded contract spans from 1st July 2025 to 31st March 2028, following the Healthcare Services (Provider Selection Regime) Regulations 2023. This award follows a direct award process without a prior call for competition, ensuring services under patient choice provision.

The procurement stage is at the 'award' phase, with the contract effectively active, and the formal signing occurred on 16th January 2025. Notably, the Mid and South Essex Integrated Care Board's Main Board authorises the contract, indicating a structured governance framework in place. This tender offers significant business growth opportunities, particularly for large-scale suppliers capable of delivering high-quality ophthalmology services.

The nature of the procurement method—being a limited, direct award—suggests that businesses with an established history of collaboration with NHS services, particularly in the Eye Care segment, are well-positioned to benefit. The contract value, estimated at £1,583,916, highlights substantial engagement potential for businesses capable of delivering high-standard healthcare services under predefined guidelines. Suppliers interested in participating in such contracts should ensure compliance with the Patient Choice and Provider Selection Regime requirements to optimise eligibility and service delivery prospects in this thriving sector.